SCHEMBL1506291

SCHEMBL1506291

COC(=O)Cc1cc(Nc2cccc(C(F)(F)F)c2)nn1-c1ccnc(C)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ THRB P10828 1/20 0.47
▸ MEN1 O00255 2/20 0.45
▸ KMT2A Q03164 2/20 0.45
▸ AURKA O14965 11/20 0.44
▸ LMNA P02545 2/20 0.43
▸ RECQL P46063 1/20 0.43
▸ PSEN1 P49768 1/20 0.42
▸ PSEN2 P49810 1/20 0.42
▸ APH1B Q8WW43 1/20 0.42
▸ NCSTN Q92542 1/20 0.42
▸ APH1A Q96BI3 1/20 0.42
▸ PSENEN Q9NZ42 1/20 0.42
▸ GPR52 Q9Y2T5 1/20 0.42
▸ SYK P43405 1/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ PHGDH O43175 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ USP2 O75604 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ HTT P42858 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1506093 0.92 THRB (0.46) THRBMEN1KMT2AAURKALMNA
SCHEMBL1506250 0.89 THRB (0.47) THRBAURKALMNARECQLGPR52
SCHEMBL1506469 0.87 MAPK1 (0.46) SYKMAPK1L3MBTL1
SCHEMBL1506201 0.87 HDAC3 (0.42) MEN1KMT2ALMNAPSEN1PSEN2
SCHEMBL1506163 0.87 THRB (0.45) THRBAURKALMNARECQLGPR52
SCHEMBL1506314 0.86 THRB (0.52) THRBKMT2AAURKALMNARECQL
SCHEMBL1506298 0.86 THRB (0.47) THRBMEN1KMT2AAURKALMNA
Isophthalic Acid SCHEMBL27864979 0.84 AURKA (0.51) THRBMEN1KMT2AAURKALMNA
SCHEMBL1506286 0.84 THRB (0.49) THRBKMT2AAURKALMNARECQL
SCHEMBL10010425 0.84 THRB (0.45) THRBMEN1KMT2AAURKALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8791144-B2 Substituted N-phenyl-1-(4-Pyridinyl)-1H-pyrazol-3-amines JANSSEN PHARMACEUTICA NV (BE) 2014-07-29 — — US disclosed
EP-2491024-B1 SUBSTITUTED N-PHENYL-1-(4-PYRIDINYL)-1H-PYRAZOL-3-AMINES JANSSEN PHARMACEUTICA NV (BE) 2013-11-20 — — EP disclosed
EP-2491024-A1 SUBSTITUTED N-PHENYL-1-(4-PYRIDINYL)-1H-PYRAZOL-3-AMINES Janssen Pharmaceutica N.V. (BE) 2012-08-29 — — EP disclosed
US-20120172354-A1 Substituted N-Phenyl-1-(4-Pyridinyl)-1H-Pyrazol-3-Amines JANSSEN PHARMACEUTICA NV (BE) 2012-07-05 — — US disclosed
WO-2011033018-A1 SUBSTITUTED N-PHENYL-1-(4-PYRIDINYL)-1H-PYRAZOL-3-AMINES JANSSEN PHARMACEUTICA NV (BE) 2011-03-24 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120172354-A1 Substituted N-Phenyl-1-(4-Pyridinyl)-1H-Pyrazol-3-Amines CHRM1, CHRNA1, CHRM3 THRB 226/4885MEN1 4021/4885KMT2A 1967/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback